Melissa Palmer

Scientific Advisor at Engitix Therapeutics

Melissa Palmer is a renowned hepatologist and experienced biopharmaceutical executive, currently the Head of Liver Disease Development at Takeda. She worked for ~25 years as a hepatologist before moving to Kadmon Pharmaceuticals then Shire. She has a BA from Columbia and trained in Medicine and Hepatology at Mount Sinai Medical School.

Location

New York, United States

Links


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Engitix Therapeutics

To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.


Industries

Employees

51-200

Links